Loading...
MTAASOL
Market cap3.46bUSD
Dec 20, Last price  
36.55EUR
1D
1.11%
1Q
8.62%
Jan 2017
358.59%
Name

SOL SpA

Chart & Performance

D1W1MN
MTAA:SOL chart
P/E
22.75
P/S
2.23
EPS
1.61
Div Yield, %
0.90%
Shrs. gr., 5y
—
Rev. gr., 5y
12.28%
Revenues
1.49b
+7.83%
320,804,332351,561,000403,555,000442,411,000472,470,000462,621,000534,041,000559,858,000582,968,000596,322,000636,360,000674,216,000703,370,000756,807,000833,513,000904,313,000973,833,0001,112,909,0001,379,187,0001,487,136,000
Net income
146m
+9.01%
16,505,08218,024,00017,682,00027,878,00035,988,00026,102,00032,827,00031,146,00029,027,00021,629,00029,181,00032,441,00044,125,00040,239,00051,880,00049,338,000103,047,00089,549,000133,693,000145,733,000
CFO
270m
+25.66%
52,46656,401,00041,096,00071,149,00065,486,00080,414,00062,075,00085,928,00087,414,00099,752,000124,512,00092,696,000117,962,000136,707,000132,609,000186,385,000199,351,000192,564,000214,919,000270,060,000
Dividend
May 20, 20240.37 EUR/sh
Earnings
Mar 26, 2025

Profile

SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases; and in home medical assistance and related medical equipment in Italy and internationally. The company offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use. It also provides home oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids. In addition, it provides medical devices; training services; InfoHealth SOLution, a web platform that allows to control plans, coordinate, and manage the activities; electromedical equipment services; hospital hygiene and environmental monitoring services; and ambulance management services. Further, it designs, constructs, and manages bio banks; distribution of medical and technical gases; produces and sells hydroelectric power; offers pre-and post-natal diagnostic screening services; produces and sells diagnostic systems; researches, develops, and markets products for research, diagnosis and clinical application in the hospital, environmental, veterinary and food sectors; and bioshipping services, as well as provides transfer, storage, and handling services of biological samples. Its products are used in the chemical, electronics, steel, metal, and food industries, as well as in environmental protection, and research and healthcare sectors. The company was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. is a subsidiary of Gas and Technologies World BV.
URL
https://www.sol.it/en
IPO date
Jul 01, 1998
Employees
Domiciled in
IT
Incorporated in
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,487,136
7.83%
1,379,187
23.93%
1,112,909
14.28%
Cost of revenue
845,649
875,176
628,982
Unusual Expense (Income)
NOPBT
641,487
504,011
483,927
NOPBT Margin
43.14%
36.54%
43.48%
Operating Taxes
57,905
42,294
32,170
Tax Rate
9.03%
8.39%
6.65%
NOPAT
583,582
461,717
451,757
Net income
145,733
9.01%
133,693
49.30%
89,549
-13.10%
Dividends
(29,931)
(21,768)
(19,954)
Dividend yield
1.19%
1.36%
1.04%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
92,156
6,860
1,643
Long-term debt
582,058
502,227
411,909
Deferred revenue
(284,684)
(232,765)
Other long-term liabilities
42,589
303,136
255,665
Net debt
429,743
340,108
260,130
Cash flow
Cash from operating activities
270,060
214,919
192,564
CAPEX
(164,383)
(161,178)
(147,752)
Cash from investing activities
(246,695)
(252,297)
(229,520)
Cash from financing activities
52,421
30,345
(93,532)
FCF
389,463
285,708
374,792
Balance
Cash
216,649
134,642
146,475
Long term investments
27,822
34,337
6,947
Excess cash
170,114
100,020
97,777
Stockholders' equity
901,332
799,296
658,117
Invested Capital
1,468,146
1,209,866
1,006,338
ROIC
43.58%
41.67%
48.08%
ROCE
38.80%
38.12%
43.54%
EV
Common stock shares outstanding
90,686
90,701
90,728
Price
27.80
57.06%
17.70
-16.31%
21.15
51.07%
Market cap
2,521,081
57.04%
1,605,404
-16.34%
1,918,907
51.10%
EV
2,997,339
1,987,528
2,202,232
EBITDA
786,252
632,961
603,224
EV/EBITDA
3.81
3.14
3.65
Interest
17,748
8,314
8,098
Interest/NOPBT
2.77%
1.65%
1.67%